Canada Life Science Market Trend Analysis 2021

In 2020, the total value of biotech equity financing in Canada, as well as the number of rounds, were slightly higher than in 2019 and the highest since 2016. Canadian companies currently have more than 700 human therapeutics in their pipelines and the country remains one of the strongest life science markets in the world. … Continue reading Canada Life Science Market Trend Analysis 2021

Read more

Canadian Life Science Market Trend Analysis 2020

Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.

Read more

Canadian Life Science Market Trend Analysis 2019

This month we are presenting the annual trend report for the Canadian life science market that shows the strong position of the country in the global biotech industry. The total financing amount of the three largest rounds of 2019 alone exceeded a quarter billion USD. Download the report Would you like to be notified about … Continue reading Canadian Life Science Market Trend Analysis 2019

Read more

Canadian Biotech Market Trend Analysis 2018

Biotechgate presents the annual life science and biotech market trend analysis for Canada. There are currently around thousand biotechnology and around a hundred pharma companies there, excluding subsidiaries of companies headquartered in other countries. The therapeutics sector is remarkably strong and three large financing round has been noted in the last 12 months.  Canadian Biotech … Continue reading Canadian Biotech Market Trend Analysis 2018

Read more

Canadian Life Sciences Trend Analysis 2017

This month we look at the Canadian life science market. 2016 was a particularly good year when it comes to investing in biotech companies there. The major financing rounds accumulated to over half a billion USD and we can see the continuation of the trend in 2017. Please click on the link below for the … Continue reading Canadian Life Sciences Trend Analysis 2017

Read more

Canadian Life Sciences Trend Analysis 2016

The amount of private Canadian biotech companies founded in 2015 was the lowest in at least 10 years, with just two new businesses entering the field. However private Biotech funding has enjoyed a small increase in total investment in H1 of 2016 when compared to the final months of last year. Download the full trend … Continue reading Canadian Life Sciences Trend Analysis 2016

Read more

Canadian Life Sciences Trend Analysis 2014

In 2013 the venture capital raised by Biotechnology companies in Canada almost doubled (93% increase) compared to the previous year’s figure, to reach a total of USD 139m. The majority of Biotech products in the industry belong to the area of oncology, followed by products developed for nervous system and for Infectious diseases indications. Distributors, … Continue reading Canadian Life Sciences Trend Analysis 2014

Read more